GPAT

ANALYST NOTE: GPAT (GP-Act III Acquisition Corp.) Date: 2026-06-13 Current Price: $10.88

1. Structural Readiness

• State: Context-Only / Forming.
• Conservative Entry: Not yet actionable (awaiting confirmed breakout).
• Aggressive/Pre-Breakout Entry: N/A (Forming coils are not standalone actionable entries; they require confirmation).
• Breakout Level: Pending confirmation above current consolidation resistance (exact level not defined in current evidence, requires price action above recent highs).
• Current Price: $10.88.
• Extension: N/A (Price is within the consolidation range, not extended above a breakout level).
• ATR Context: Current ATR is 0.3% (sub-threshold). This indicates low volatility and a lack of immediate momentum, consistent with a "Forming" state where the market is digesting the timeline to the November 2026 deadline.

2. Thesis Layer

• Thesis Classification: TACTICAL / SETUP-LED.
• Macro Thesis: There is NO named secular thesis attached to this name as of 2026-06-13. The evidence does not support a specific macro-driven narrative (e.g., "AI Infrastructure" or "Energy Transition") for GPAT itself.
• Judgment Criteria: Conviction must be derived strictly from the quality of the setup structure (the "Forming" coil) and the fundamental business model of the SPAC vehicle (management track record, trust account integrity, and target criteria), rather than a pre-existing macro tailwind.

3. The Business

• Entity Type: GP-Act III Acquisition Corp. is a blank-check company (SPAC) formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more target businesses.
• Business Model: The company does not currently operate a commercial business. Its primary function is to raise capital via its Initial Public Offering (IPO) and hold those funds in a Trust Account until a target is identified and a business combination is completed.
• Industry: Financial Services (Special Purpose Acquisition Company).
• Target Criteria (Management Expectations):
• Sector Focus: Management intends to focus on high-potential businesses based in the United States (Evidence E5).
• Valuation Range: Target enterprise valuation between $1.0 billion and $5.0 billion (Evidence E5).
• Quality Metrics: Targets must have strong demand, limited competition, or differentiated technology/business models (Evidence E8).
• Deal Threshold: The target must have a fair market value equal to at least 80% of the net assets held in the Trust Account (Evidence E2, E9).
• Timeline (Management Expectations):
• IPO Date: May 13, 2024 (Evidence E12).
• Combination Deadline: The company has until November 13, 2026, to complete a business combination (Evidence E1, E6).
• Current Status (as of 2026-06-13): The company is in the "Combination Period" (approx. 18 months post-IPO, 5 months remaining before the deadline).

4. Archetype and Conviction

• Archetype: Growth Leader (Source: Layer A).
• *Fit:* This classification is based on the management's stated intent to target companies with "sustainable competitive advantage" and "positive secular trends" (Evidence E11) and a track record of guiding companies through IPOs (Evidence E10). However, as a SPAC, the "Growth Leader" status is aspirational and contingent on the successful identification and closing of a target.
• Valuation Context:
• The current price of $10.88 suggests a slight premium to the typical $10.00 trust floor, indicating the market is pricing in a non-zero probability of a successful deal before the November 2026 deadline.
• No specific P/E or EV/EBITDA multiples are available as the company has no operating revenue.
• Conviction Stack:
• Thesis Strength: Low (No specific target named; purely tactical).
• Evidence Quality: High (Clear SEC filings defining the 80% test, timeline, and management track record).
• Structural Quality: Moderate. The "Forming" coil indicates stability, but the sub-threshold ATR (0.3%) suggests a lack of volatility-driven opportunity at this exact moment.
• Rerating Potential: Binary. The stock will likely rerate significantly only upon the announcement of a specific target (deal announcement) or face de-rating if the deadline approaches without a deal.

5. Invalidations, Strengths, and Gaps

• What Would Invalidate:
• Management announcing an extension of the deadline beyond November 13, 2026, without a clear path to a deal (though the current filing states the deadline is fixed).
• What Would Strengthen:
• Announcement of a Letter of Intent (LOI) or definitive agreement with a target company meeting the $1.0B–$5.0B valuation criteria.
• A confirmed breakout above the current consolidation range with volume, signaling market anticipation of a deal.
• Gaps in Evidence:
• Target Identity: No specific target company is named in the evidence as of 2026-06-13.
• Financials of Target: No financial data exists for the target business.
• Deal Terms: No information on redemption rates, PIPE (Private Investment in Public Equity) size, or specific deal structure.
• Management Activity: While the track record is cited, there is no evidence of specific recent negotiations or due diligence progress in the provided filings.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: low Key evidence: Management has a defined 80% fair market value test and a clear November 2026 deadline; Current price ($10.88) holds above the $10.00 structural floor; Management targets $1B-$5B US-based companies with strong competitive advantages. Key risks: No target identified as of June 2026; Sub-threshold volatility (0.3% ATR) indicates lack of momentum; Binary outcome risk if deal fails before November 2026 deadline; Potential for liquidation if no deal is found. Sizing hint: Position size should be minimal or zero until a specific target is announced or a confirmed breakout occurs. Expected path: Price likely remains range-bound near $10.00-$11.00 until a target is announced; potential for sharp move on deal news or liquidation announcement. Expected horizon: 5 months (until November 13, 2026 deadline). Failure mode to watch: Price closing below $10.00, signaling loss of trust floor support and potential liquidation.